Drug Trial Radar · NCT00324571
Dialysis Clinical Outcomes Revisited (DCOR) Trial
Last checked: Nov 20, 2026Latest source record: Mar 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,000
Actual
Start
Mar 2001
Primary completion
Not stated
Study completion Feb 2006
Sponsor
- Lead sponsor
- Genzyme, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- May 11, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients. Informed consent will be obtained and the inclusion/exclusion criteria reviewed. Eligible patients will be randomized to receive either Renagel or a calcium-based binder. Starting from the randomization date, mortality data including survival, death date and cause of death (vital status information) and morbidity data including hospitalization date will be recorded for all patients. These data will be collected until the end of the study (December 31, 2004, ± 2 weeks). Patients completing or terminating from the study will return to the phosphate binder prescribed by their usual healthcare provider.
Conditions
- Chronic Kidney Disease
Interventions
Sevelamer hydrochlorideDrug
Calcium-based phosphate binderDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy will be evaluated based on a comparison of the association of Renagel use versus calcium-based phosphate binder use on all-cause mortality, cause-specific mortality (cardiovascular, infection, other), and all-cause hospitalization.
- Safety will be assessed based on an evaluation of related serious adverse events.
Locations
73 sites in 2 countries. Site status is shown where the registry gives one.
Gambro Healthcare-Gadsden
Gadsden, Alabama
nTouch Research
Huntsville, Alabama
Kidney Health Institute, LLC
Tucson, Arizona
Gambro Healthcare
El Cerrito, California
Palomar Medical Group
Escondido, California
Gambro Healthcare-Los Angeles
Los Angeles, California
Balboa Nephrology Medical Group
San Diego, California
Nephrology Educational Services and Research
Tarzana, California
Lowry Dialysis Center
Denver, Colorado
Nephrology Associates, P.C.
Bridgeport, Connecticut
Gambro Healthcare-Hartford
Hartford, Connecticut
Nephrology Associates
New Britain, Connecticut
InterAmerican Dialysis
Coral Gables, Florida
DaVita Crystal River Dialysis
Crystal River, Florida
Gambro Healthcare-Miami
Miami, Florida
Miami Kidney Group
Miami, Florida
Pensacola Nephrology, P.A.
Pensacola, Florida
Gambro Healthcare-Plantation
Plantation, Florida
America Dialysis
St. Petersburg, Florida
Genesis Clinical Research Corp
Tampa, Florida
Gambro Healthcare-Americus
Americus, Georgia
nTouch Research
Atlanta, Georgia
Gambro Healthcare-Douglas
Douglas, Georgia
Gambro Healthcare-Douglasville
Douglasville, Georgia
Dublin Nephrology
Dublin, Georgia
Georgia Kidney Associates, Inc.
Marietta, Georgia
Gambro Healthcare-Rome
Rome, Georgia
Gambro Healthcare-Savannah
Savannah, Georgia
MacNeal Renal Lifeline Services
Berwyn, Illinois
Southwest Nephrology
Evergreen Park, Illinois
Horizon Healthcare Associates
Olympia Fields, Illinois
Renal Care Associates, S.C.
Peoria, Illinois
Gambro Healthcare-Springfield Central
Springfield, Illinois
Lincolnland Dialysis
Springfield, Illinois
Nephrology Specialists, PC.
Valparaiso, Indiana
Wichita Dialysis Center East
Wichita, Kansas
Wichita Nephrology
Wichita, Kansas
Northwest Louisiana Nephrology, LLC.
Shreveport, Louisiana
BMA of Washington
Bethesda, Maryland
Gambro Healthcare-Frederick
Frederick, Maryland
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.